Drug intelligence / Profile preview

MitoCEHC

Development stage
Preclinical
Modality
Small Molecules
01

Overview

MitoCEHC is a mitochondria-targeted antioxidant conjugate consisting of the vitamin E metabolite **α-CEHC** (2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman) linked to a lipophilic **triphenylphosphonium (TPP)** cation via a lysine linker. The TPP moiety facilitates the selective accumulation of the molecule within the mitochondrial matrix, driven by the mitochondrial membrane potential. Once localized, the α-CEHC component acts as a potent scavenger of reactive oxygen species (ROS), thereby mitigating oxidative stress and mitochondrial dysfunction. Research has demonstrated its efficacy in reducing oxidative damage in endothelial cells and its ability to accumulate in the mitochondria of diabetic mouse models (*db/db*), suggesting potential therapeutic utility in metabolic and cardiovascular diseases characterized by oxidative injury.

Other names
mitochondrial triphenylphosphonium-alpha-CEHCTPP-lysine-alpha-CEHCalpha-CEHC-TPP

Beyond the preview

Go deeper on MitoCEHC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MitoCEHC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call